The obtained PCR products can be used for TA cloning! A reagent for experimental research characterized by high DNA yield.
The "Hot-Start Gene Taq" we handle is a heat-resistant DNA polymerase for hot start PCR, which undergoes enzyme activation treatment at 95°C for 5 minutes before entering the PCR cycle. It is a modified Taq DNA polymerase called "Gene Taq FP," which minimizes contamination from host bacterial DNA and has been chemically modified. The resulting PCR products can be used for TA cloning. Additionally, this product comes with two types of reaction buffers: the conventional 10 x Gene Taq Universal Buffer and the 10 x Brilliant Buffer. 【Features】 ■ High specificity and high DNA yield ■ Hot-Start function allows for reaction mixture preparation at room temperature ■ Suitable for multiplex PCR ■ Comes with two types of buffers that can be used according to experimental conditions *For more details, please refer to the related links or feel free to contact us.
Inquire About This Product
basic information
【Product Contents (Partial)】 <Hot-Start Gene Taq (50 units)> ■ Components ・Hot-Start Gene Taq ・dNTP Mixture (2.5 mmol/l each) ・10 x Gene Taq Universal Buffer (15 mmol/l Mg2+) ・10 x Brilliant Buffer (20 mmol/l Mg2+) *For more details, please refer to the related links or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■Hot Start PCR ■Multiplex PCR *For more details, please refer to the related links or feel free to contact us.
Company information
Our company is a product development-oriented enterprise that utilizes biotechnology. We develop and manufacture in vitro diagnostic pharmaceuticals (such as pregnancy tests and ovulation tests), diagnostic drugs for environmental, food, and animal and plant diseases, and reagents for genetic engineering research, using our expertise in gene and antibody technology. We hold manufacturing registration and manufacturing and sales licenses for both human and animal products, with over 30 years of experience in the manufacture of in vitro diagnostic pharmaceuticals. Additionally, we are engaged in personalized medicine, advancing research and development of diagnostic drugs using genetic polymorphism analysis and gene expression analysis.
